Shilpa Medicare Limited — Important, 06-05-2025: General Updates

Shilpa Medicare has announced a board meeting. Its Unit VI in Bengaluru secured EMA approval for manufacturing Oral Mouth Dissolving Films and Transdermal Systems, complementing existing MHRA and TGA approvals. This paves the way for entry into the EU market with these advanced drug delivery forms, strengthening Shilpa’s pipeline and growth potential in niche, tech-driven dosage products.